Omontys Overdose

It is possible -- and quite dangerous -- to overdose on Omontys (peginesatide), as it can cause the red blood cells in the body to increase too quickly or too much. As a result, it may cause potentially serious complications, such as a heart attack, stroke, or blood clot. Seek immediate medical attention if you believe you have received too much of this medication.

In February 2013, Omontys was pulled from the market (all of the product was recalled) to investigate reports of dangerous allergic reactions, including fatal anaphylactic reactions, which appear to be occurring more frequently than anticipated. This medication will not be available until further notice.

Can You Receive Too Much Omontys?

Omontys® (peginesatide) is a prescription medication used to treat anemia. It belongs to a group of medications known as erythropoiesis-stimulating agents (ESAs). As with most medications, it is possible to receive too much Omontys.
The specific effects of an overdose can vary, depending on a number of factors, including the Omontys dosage and whether a person has certain risk factors for heart disease, strokes, or blood clots.

Effects of an Overdose

Omontys works by stimulating the production of red blood cells. The expected symptoms of an Omontys overdose are caused by the red blood cells increasing too quickly or too much. This can be quite dangerous, increasing the risk for the following effects:

Treatment for an Omontys Overdose

If the red blood cells increase too much, this can be corrected by removing blood. This is the same process as donating blood, although the blood is not donated. Treatment may also include supportive care, which consists of treating the symptoms that occur as a result of the overdose.
It is important that you seek medical attention immediately if you believe that you or someone else may have received too much of this medication.

Omontys Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.